CLASS II ONGOING Drug recall · Reported 23 Sep 2026 · FDA Enforcement Report
Chlorthalidone Tablets, USP, 25 mg recalled by Inventia Healthcare
Inventia Healthcare is recalling Chlorthalidone Tablets, USP, 25 mg per, distributed nationwide in the US. The recall was initiated on 3 Sep 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0852-2026
- FDA event ID
- 99806
- Recalling firm
- Inventia Healthcare, Kalyan, N/A
- Brand
- Chlorthalidone
- Manufacturer
- Rising Pharma Holdings, Inc.
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 3 Sep 2026
- FDA classified
- 17 Sep 2026
- Reported
- 23 Sep 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Blood Pressure Medication
Timeline
| 3 Sep 2026 | Recall initiated by company | |
| 17 Sep 2026 | Classified by FDA | +14 days |
| 23 Sep 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Dissolution Specifications
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Where it was distributed
U.S. Nationwide
Questions about this recall
Why was it recalled?
Failed Dissolution Specifications
Which lots are affected?
Batch # RISA24002; Exp Date: 04/2027
Where was it sold?
U.S. Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 29 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Inventia Healthcare
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone | Inventia Healthcare | Potency & Assay | Nationwide |
Other Chlorthalidone recalls
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone | Inventia Healthcare | Potency & Assay | Nationwide |
| Drug | CLASS II | Chlorthalidone Tablets, USP, 25 mg Unit Dose cards recalled by AvKAREChlorthalidone | AvKARE | Potency & Assay | Nationwide |
| Drug | CLASS II | Chlorthalidone Tablets, USP, 25MG recalled by Cardinal HealthcareChlorthalidone | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Chlorthalidone Tablets USP 25 mg recalledChlorthalidone | SUN Pharmaceutical Industries | Particulate Matter | Nationwide |
| Drug | CLASS II | Chlorthalidone, Tablet, 50 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |